Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Kazia Therapeutics Ltd (KZIA US)
Watchlist
11
Analysis
Health Care
•
Australia
Kazia Therapeutics Limited operates as an biotechnology company. The Company develops anti-cancer drugs, as well as provides pharmaceutical research and development technology solutions. Kazia Therapeutics serves customers globally.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Kazia Therapeutics Ltd
•
01 Feb 2023 16:56
•
Issuer-paid
Kazia Therapeutics - Reinvestment period with increased R&D focus
Kazia Therapeutics has released its Q223 activity report and provided a business update for the quarter. Q2 was marked by increased preclinical...
Edison Investment Research
Follow
222 Views
Share
bullish
•
Kazia Therapeutics Ltd
•
19 Dec 2022 21:00
•
Issuer-paid
Kazia Therapeutics - Collaboration may expand utility to combo therapies
Kazia Therapeutics has announced a research collaboration with QIMR Berghofer Medical Research Institute (an Australia-based cancer research...
Edison Investment Research
Follow
675 Views
Share
bullish
•
Kazia Therapeutics Ltd
•
07 Dec 2022 23:44
•
Issuer-paid
Kazia Therapeutics - EVT801 data published in peer-reviewed journal
Kazia Therapeutics has announced the publication of pre-clinical data for its second pipeline asset, EVT801 in the journal Cancer Research...
Edison Investment Research
Follow
681 Views
Share
bullish
•
Kazia Therapeutics Ltd
•
01 Nov 2022 21:10
•
Issuer-paid
Kazia Therapeutics - Q123 cash flows in line with our estimates
Kazia Therapeutics’ Q123 cash flow report provided an update on the company’s financial position and business progress. While the quarter was...
Edison Investment Research
Follow
393 Views
Share
bullish
•
Kazia Therapeutics Ltd
•
10 Oct 2022 22:52
•
Issuer-paid
Kazia Therapeutics - PNOC022 trial expanded
Kazia Therapeutics has announced the expansion of the PNOC022 (NCT05009992) trial to two new sites in Australia. The Phase II trial is...
Edison Investment Research
Follow
676 Views
Share
1
2
3
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.1
x